55 results
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
of $0.0001 per share of common stock, subject to beneficial ownership limitations). The holders of a majority in voting power of the shares of common stock … , the affirmative vote of the majority of votes cast affirmatively or negatively (excluding abstentions) is required for approval. This is a routine proposal so we do
SC TO-I
EX-99
okdqapdc nfss9
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
j3e3opiv9cdpya1m7
30 Jan 24
Issuer tender offer statement
7:04am
424B3
0ilz5gfnqfofcap9
28 Nov 23
Prospectus supplement
4:01pm
8-K
EX-10.1
e0939
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-99.1
d38qt
3 Aug 23
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2023 Financial Results
4:05pm
8-K
EX-99.1
nsyszhmc4f 04kj7m
4 May 23
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2023 Financial Results
4:05pm